{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:14:08Z","timestamp":1783300448660,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20230484295"],"award-info":[{"award-number":["20230484295"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05125-1","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:05:32Z","timestamp":1778555132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro and in vivo activity of eravacycline against Mycobacterium abscessus"],"prefix":"10.1186","volume":"26","author":[{"given":"Kai","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"5125_CR1","doi-asserted-by":"crossref","unstructured":"Lopeman RC, Harrison J, Desai M, et al. Mycobacterium abscessus: Environmental Bacterium Turned Clinical Nightmare [J]. Microorganisms. 2019;7(3):90.","DOI":"10.3390\/microorganisms7030090"},{"key":"5125_CR2","doi-asserted-by":"crossref","unstructured":"To K, Cao R, Yegiazaryan A, et al. General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus [J]. J Clin Med. 2020;9(8):2541.","DOI":"10.3390\/jcm9082541"},{"key":"5125_CR3","doi-asserted-by":"crossref","unstructured":"Abdelaal HFM, Chan ED, Young L, et al. Mycobacterium abscessus: It's Complex [J]. Microorganisms. 2022;10(7):1454.","DOI":"10.3390\/microorganisms10071454"},{"issue":"1","key":"5125_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2214\/AJR.07.2074","volume":"189","author":"S Martinez","year":"2007","unstructured":"Martinez S, Mcadams HP, Batchu CS. The many faces of pulmonary nontuberculous mycobacterial infection [J]. AJR Am J Roentgenol. 2007;189(1):177\u201386.","journal-title":"AJR Am J Roentgenol"},{"key":"5125_CR5","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.002005","author":"CS Pedace","year":"2025","unstructured":"Pedace CS, Arbeit RD, DOS SANTOS SIME\u00e3O FC, et al. Drug susceptibility profiles of Mycobacterium abscessus isolated in the state of S\u00e3o Paulo, 2008-2024. J Med Microbiol. 2025. https:\/\/doi.org\/10.1099\/jmm.0.002005.","journal-title":"J Med Microbiol"},{"issue":"7","key":"5125_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","volume":"103","author":"DE Brodersen","year":"2000","unstructured":"Brodersen DE, Clemons WM, Carter AP, et al. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit [J]. Cell. 2000;103(7):1143\u201354.","journal-title":"Cell"},{"issue":"1","key":"5125_CR7","doi-asserted-by":"publisher","first-page":"e0323822","DOI":"10.1128\/spectrum.03238-22","volume":"11","author":"T Zhang","year":"2023","unstructured":"Zhang T, Du J, Dong L, et al. In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria [J]. Microbiol Spectr. 2023;11(1):e0323822.","journal-title":"Microbiol Spectr"},{"key":"5125_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.rmed.2019.10.006","volume":"158","author":"YS Kwon","year":"2019","unstructured":"Kwon YS, Levin A, Kasperbauer SH, et al. Efficacy and safety of tigecycline for Mycobacterium abscessus disease [J]. Respir Med. 2019;158:89\u201391.","journal-title":"Respir Med"},{"issue":"7","key":"5125_CR9","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/jac\/dku062","volume":"69","author":"RJ Wallace","year":"2014","unstructured":"Wallace RJ, Dukart G, Brown-Elliott BA, et al. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother. 2014;69(7):1945\u201353.","journal-title":"J Antimicrob Chemother"},{"key":"5125_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jgar.2025.06.021","volume":"44","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Teo JQM, Chang HY, et al. Comparative in vitro activities of eravacycline and tigecycline against carbapenem-resistant Acinetobacter baumannii: insights from whole genome sequencing analysis [J]. J Glob Antimicrob Resist. 2025;44:340\u20136.","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"5125_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","volume":"76","author":"GG Zhanel","year":"2016","unstructured":"Zhanel GG, Cheung D, Adam H, et al. Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent [J]. Drugs. 2016;76(5):567\u201388.","journal-title":"Drugs"},{"key":"5125_CR12","doi-asserted-by":"publisher","first-page":"802133","DOI":"10.3389\/fmicb.2021.802133","volume":"12","author":"L Huang","year":"2021","unstructured":"Huang L, Li H, Ren W, et al. Highly Discriminative Genotyping of Mycobacterium abscessus Complex Using a Set of Variable Number Tandem Repeats in China [J]. Front Microbiol. 2021;12:802133.","journal-title":"Front Microbiol"},{"issue":"6","key":"5125_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/infdis\/jiad007","volume":"227","author":"W Hedin","year":"2023","unstructured":"Hedin W, FR\u00f6BERG G, Fredman K, et al. A rough colony morphology of Mycobacterium abscessus is associated with cavitary pulmonary disease and poor clinical outcome. J Infect Dis. 2023;227(6):820\u20137.","journal-title":"J Infect Dis"},{"key":"5125_CR14","volume-title":"Performance standards for susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomycetes","author":"INSTITUTE C A L S","year":"2023","unstructured":"INSTITUTE C A L S. Performance standards for susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomycetes. Wayne, PA: Clinical and Laboratory Standards Institute; 2023."},{"issue":"6","key":"5125_CR15","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1128\/AAC.00986-07","volume":"52","author":"R Greendyke","year":"2008","unstructured":"Greendyke R, Byrd TF. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria [J]. Antimicrob Agents Chemother. 2008;52(6):2019\u201326.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5125_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1469-0691.2007.01698.x","volume":"13","author":"JC Palomino","year":"2007","unstructured":"Palomino JC, Martin A, Portaels F. Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods [J]. Clin Microbiol Infect. 2007;13(8):754\u201362.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5125_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3346\/jkms.2008.23.1.49","volume":"23","author":"S Park","year":"2008","unstructured":"Park S, Kim S, Park EM, et al. In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea [J]. J Korean Med Sci. 2008;23(1):49\u201352.","journal-title":"J Korean Med Sci"},{"issue":"8","key":"5125_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00648-24","volume":"68","author":"B Rimal","year":"2024","unstructured":"Rimal B, Lippincott CK, Panthi CM, et al. Efficacy of epetraborole against Mycobacteroides abscessus in a mouse model of lung infection [J]. Antimicrob Agents Chemother. 2024;68(8):e0064824.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"5125_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084065","volume":"8","author":"G Li","year":"2013","unstructured":"Li G, Lian LL, Wan L, et al. Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assay. PLoS ONE. 2013;8(12):e84065.","journal-title":"PLoS ONE"},{"issue":"6","key":"5125_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/infdis\/jit614","volume":"209","author":"I Lerat","year":"2014","unstructured":"Lerat I, Cambau E, Roth DitBettoni R, et al. In vivo evaluation of antibiotic activity against Mycobacterium abscessus [J]. J Infect Dis. 2014;209(6):905\u201312.","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"5125_CR21","doi-asserted-by":"publisher","first-page":"S333","DOI":"10.1086\/431674","volume":"41","author":"AK Meagher","year":"2005","unstructured":"Meagher AK, Ambrose PG, Grasela TH, et al. The pharmacokinetic and pharmacodynamic profile of tigecycline [J]. Clin Infect Dis. 2005;41(Suppl 5):S333\u201340.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5125_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40262-019-00767-z","volume":"58","author":"MW Mccarthy","year":"2019","unstructured":"Mccarthy MW. Clinical pharmacokinetics and pharmacodynamics of eravacycline. Clin Pharmacokinet. 2019;58(9):1149\u201353.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"5125_CR23","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/jac\/dkaa110","volume":"75","author":"C Pearce","year":"2020","unstructured":"Pearce C, Ruth MM, Pennings LJ, et al. Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo [J]. J Antimicrob Chemother. 2020;75(7):1889\u201394.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"5125_CR24","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.jfma.2020.05.002","volume":"119","author":"WC Huang","year":"2020","unstructured":"Huang WC, Yu MC, Huang YW. Identification and drug susceptibility testing for nontuberculous mycobacteria. J Formos Med Assoc. 2020;119(Suppl 1):S32-s41.","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"5125_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jac\/dkr578","volume":"67","author":"R Nessar","year":"2012","unstructured":"Nessar R, Cambau E, Reyrat JM, et al. Mycobacteriumabscessus: a new antibiotic nightmare. J Antimicrob Chemother. 2012;67(4):810\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5125_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00689-22","volume":"66","author":"BARJ Brown-ElliottWallace","year":"2022","unstructured":"Brown-ElliottWallace BARJ. In vitro susceptibility testing of eravacycline against nontuberculous mycobacteria. Antimicrob Agents Chemother. 2022;66(9):e0068922.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5125_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01031-21","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Morgan CE, Bonomo RA, et al. Cryo-EM determination of Eravacycline-bound structures of the ribosome and the multidrug efflux pump AdeJ of Acinetobacter baumannii. MBio. 2021;12(3):e0103121.","journal-title":"MBio"},{"issue":"9","key":"5125_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41594-023-01047-y","volume":"30","author":"H Paternoga","year":"2023","unstructured":"Paternoga H, Crowe-Mcauliffe C, Bock LV, et al. Structural conservation of antibiotic interaction with ribosomes. Nat Struct Mol Biol. 2023;30(9):1380\u201392.","journal-title":"Nat Struct Mol Biol"},{"key":"5125_CR29","unstructured":"Singh S, Shrivastava A, Boorgula GD, et al. Eravacycline pharmacokinetics\/pharmacodynamics in the hollow fiber system model of Mycobacterium abscessus lung disease [J]. Microbiol Spectr. 202614(1):e0343225."},{"key":"5125_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00275-18","author":"V Petraitis","year":"2018","unstructured":"Petraitis V, Petraitiene R, Maung BBW, et al. Pharmacokinetics and comprehensive analysis of the tissue distribution of Eravacycline in rabbits. Antimicrob Agents Chemother. 2018. https:\/\/doi.org\/10.1128\/AAC.00275-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5125_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/jac\/dkp301","volume":"64","author":"JL Crandon","year":"2009","unstructured":"Crandon JL, Kim A, Nicolau DP. Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. J Antimicrob Chemother. 2009;64(4):837\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5125_CR32","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1189\/jlb.1007696","volume":"83","author":"D Ordway","year":"2008","unstructured":"Ordway D, Henao-Tamayo M, Smith E, et al. Animal model of Mycobacterium abscessus lung infection [J]. J Leukoc Biol. 2008;83(6):1502\u201311.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"5125_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline [J]. Clin Infect Dis. 2020;71(4):e1\u201336.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05125-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:15:38Z","timestamp":1783296938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05125-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5125"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05125-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Beijing Chest Hospital Ethics Committee (No. BJXK-2021-KY-32). The requirement for informed consent was waived by Beijing Chest Hospital Ethics Committee due to the use of de-identified clinical isolates. The study was conducted in accordance with the Declaration of Helsinki. All animal procedures were approved by the Ethics Committee of the Experimental Animal Care of Beijing Chest Hospital, Capital Medical University (XK2023-127).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"593"}}